Skip to main content

Why is phentermine a controlled substance?

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 9, 2022.

Official answer

by Drugs.com

Phentermine is a stimulant that is chemically like amphetamine and carries a risk of dependence and abuse, which is why it is a controlled substance and only available on prescription. But the potential for dependence and abuse is lower with phentermine than other stimulants, such as amphetamine, methylphenidate, or narcotics, which is why it is a Schedule 4 controlled substance, rather than being in a higher schedule class, such as schedule 2 or 3.

Schedule 4 controlled substances are usually prescribed medications with a low risk of developing a substance use disorder. Schedule 4 controlled substances cannot be filled or refilled more than 5 times, or more than 6 months after the date the prescription was issued.

References
  • Diversion Control Division. US Department of Justice. https://www.deadiversion.usdoj.gov/schedules/
  • Drug Classifications: Schedule 1-5 Drugs. Duffy’s Rehab Center. https://www.duffysrehab.com/resources/articles/schedule-of-drugs/

Read next

Obesity is a major risk factor for covid-19 and people who are obese are more likely than those who are not obese to contract Covid-19 at a younger age, develop severe Covid-19, require hospitalization, oxygen, mechanical ventilation, intubation, or admission into ICU, end up in hospital sooner, or die from Covid-19. Continue reading

The most common side effects with Ozempic include stomach problems, like nausea, vomiting, diarrhea, stomach pain and constipation. These tend to be mild-to-moderate and usually clear up in a few weeks in most people. Low blood sugar (hypoglycemia) is also a common side effect (when used with certain other diabetes treatments) and it can be serious. Continue reading

Mounjaro and Ozempic are prescription medicines used alongside diet and exercise to help control blood sugar (glucose) levels in adults with type 2 diabetes. Ozempic is also approved to lower the risk of a major cardiovascular event (like a heart attack or stroke) in patients with type 2 diabetes. Mounjaro has not yet received this indication, although studies are ongoing. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer